Stocks and Investing Stocks and Investing
Fri, December 16, 2022

Tiago Fauth Initiated (VRDN) at Buy and Held Target at $51 on, Dec 16th, 2022


Published on 2024-10-28 00:37:32 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $51 on, Dec 16th, 2022.

Tiago has made no other calls on VRDN in the last 4 months.



There are 3 other peers that have a rating on VRDN. Out of the 3 peers that are also analyzing VRDN, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Tiago


  • Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Thursday, December 1st, 2022
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Tuesday, November 15th, 2022
  • Michael Higgins of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $40 on, Tuesday, August 16th, 2022

Contributing Sources